SpyGlass Pharma, Inc. (SGP)
26.03
-0.39
(-1.48%)
USD |
NASDAQ |
Aug 31, 14:09
SpyGlass Pharma Total Liabilities (Quarterly) : 11.07M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.07M |
| March 31, 2026 | 8.274M |
| December 31, 2025 | 10.63M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 12.15M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 243.43M |
| Shareholders Equity (Quarterly) | 232.36M |
| Debt to Equity Ratio | 0.007 |
| Current Ratio | 25.06 |
| Net Debt Paydown Yield | 0.06% |